International Life Sciences Institute Return to ILSI Home Page »

ILSI is a global network of scientists devoted to enhancing the scientific basis for public health decision-making


ILSI Europe HOME PAGE

Member Login

Not registered?
Register here!

FEATURED TOPICS

CONTACT US

by email:
info@ilsieurope.be

by phone:
+32 2 771 00 14 tel
+32 2 762 00 44 fax

by mail:
Avenue E. Mounier 83, Box6
Brussels B-1200
BELGIUM

ILSI

Human Exposure and Internal Dose Assessments of Acrylamide in Food

2005

E. Dybing et al.

Published in Food and Chemical Toxicology 2005; 43:365-410

This review provides a framework contributing to the risk assessment of acrylamide in food. It is based on the outcome of the ILSI Europe FOSIE process, a risk assessment framework for chemicals in foods and adds to the overall framework by focusing especially on exposure assessment and internal dose assessment of acrylamide in food. Since the finding that acrylamide is formed in food during heat processing and preparation of food, much effort has been (and still is being) put into understanding its mechanism of formation, on developing analytical methods and determination of levels in food, and on  evaluation of its toxicity and potential toxicity and potential human health consequences. Although several exposure estimations have been proposed, a systematic review of key information relevant to exposure assessment is currently lacking. The European and North American branches of the International Life Sciences Institute, ILSI, discussed critical aspects of exposure assessment, parameters influencing the outcome of exposure assessment and summarized data relevant to the acrylamide exposure assessment to aid the risk characterisation process. This paper reviews the data on acrylamide levels in food including its formation and analytical methods, the determination of human consumption patterns, dietary intake of the general population, estimation of maximum intake levels and identification of groups of potentially high intakes. Possible options and consequences of mitigation efforts to reduce exposure are discussed. Furthermore the association of intake levels with biomarkers of exposure and internal dose, considering aspects of bioavailability, is reviewed, and a physiologically-based toxicokinetic (PBTK) model is described that provides a good description of the kinetics of acrylamide in the rat. Each of the sections concludes with a summary of remaining gaps and uncertainties.

To download the full document, click here

To order free copies: publications@ilsieurope.be

Documents on this page may contain .PDF files which require Adobe Acrobat.
To obtain a free copy of Adobe Acrobat click below.

Get Adobe Acrobat

Acrobat and the Acrobat logo are trademarks of Adobe Systems Incorporated.